cysteamine has been researched along with Nephrotic Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cairns, D; Di Salvo, A; Kay, G; Knott, RM; Omran, Z | 1 |
| Cairns, D; Hector, EE; Kay, G; Knott, RM; Omran, Z | 1 |
| Benylles, A; Cairns, D; Kay, G; Knott, RM; Moloney, KA; Omran, Z | 1 |
| Higashi, S; Ito, S; Matsunoshita, N; Nozu, K; Otani, M; Tokuhiro, E | 1 |
| Arcolino, FO; Elmonem, MA; Levtchenko, E; van den Heuvel, L; Veys, KR | 1 |
| Dimitriou, E; Emma, F; Karavitakis, EM; Kosma, K; Michelakakis, H; Xaidara, A | 1 |
| Brugnara, M; Emma, F; Greco, M; Pastore, A; Taranta, A; Zaffanello, M | 1 |
| Antignac, C; Brodin-Sartorius, A; Charbit, M; Cochat, P; Guest, G; Legendre, C; Lesavre, P; Moyse, D; Niaudet, P; Ottolenghi, C; Servais, A; Tête, MJ | 1 |
| Bouazza, N; Chadefaux-Vekemans, B; Deschenes, G; Niaudet, P; Ottolenghi, C; Ricquier, D; Tréluyer, JM; Urien, S | 1 |
| Bagger, MJ; Cochat, P; Cornelissen, E; Deschênes, G; Gaillard, S; Greenbaum, LA; Grimm, P; Langman, CB; Matossian, D; Morin, D; Niaudet, P; Rioux, P; Sarwal, M | 1 |
| Buchan, B; Cairns, D; Kay, G; Matthews, KH | 1 |
| Cabrera, BL; Dohil, R | 1 |
1 review(s) available for cysteamine and Nephrotic Syndrome
| Article | Year |
|---|---|
Nephropathic cystinosis: an update.
Topics: Cysteamine; Cystinosis; Female; Forecasting; Genetic Therapy; Humans; Infant; Infant, Newborn; Male; Nephrotic Syndrome; Prognosis; Risk Assessment; Severity of Illness Index; Stem Cell Transplantation; Treatment Outcome | 2017 |
2 trial(s) available for cysteamine and Nephrotic Syndrome
| Article | Year |
|---|---|
Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
Topics: Adolescent; Adult; Body Weight; Child; Child, Preschool; Cysteamine; Cystine; Cystinosis; Dose-Response Relationship, Drug; Fanconi Syndrome; Female; Humans; Infant; Male; Nephrotic Syndrome; Radiation-Protective Agents; Treatment Outcome; Young Adult | 2011 |
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.
Topics: Adolescent; Adult; Child; Cross-Over Studies; Cysteamine; Cystine; Cystinosis; Delayed-Action Preparations; Fanconi Syndrome; Female; Humans; Leukocytes; Male; Nephrotic Syndrome; Young Adult | 2012 |
9 other study(ies) available for cysteamine and Nephrotic Syndrome
| Article | Year |
|---|---|
PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis.
Topics: Cells, Cultured; Cystamine; Cystinosis; Fanconi Syndrome; Fibroblasts; Humans; Nephrotic Syndrome; Polyethylene Glycols; Prodrugs | 2011 |
Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis.
Topics: Administration, Oral; Cell Line; Cystamine; Cystinosis; Fanconi Syndrome; Humans; Nephrotic Syndrome; Prodrugs | 2011 |
Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis.
Topics: Cystamine; Cystinosis; Fanconi Syndrome; Fibroblasts; Glutarates; Humans; Nephrotic Syndrome; Prodrugs; Succinic Acid | 2011 |
Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
Topics: Child; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Male; Nephrotic Syndrome; Slit Lamp Microscopy | 2017 |
Chitotriosidase plasma activity in nephropathic cystinosis.
Topics: Child, Preschool; Cysteamine; Cystinosis; Fanconi Syndrome; Hexosaminidases; Humans; Nephrotic Syndrome | 2009 |
Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Cysteamine; Cystinosis; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Fanconi Syndrome; Female; Humans; Infant; Italy; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Logistic Models; Male; Nephrotic Syndrome; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Topics: Adolescent; Adult; Age Factors; Amino Acid Transport Systems, Neutral; Child; Child, Preschool; Cysteamine; Cystinosis; Diabetes Complications; Disease Progression; Educational Status; Employment; Fanconi Syndrome; Female; Follow-Up Studies; Humans; Hypothyroidism; Infant; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Nervous System Diseases; Neuromuscular Diseases; Radiation-Protective Agents; Young Adult | 2012 |
Suppository formulations as a potential treatment for nephropathic cystinosis.
Topics: Chemistry, Pharmaceutical; Cysteamine; Cystine; Cystinosis; Drug Stability; Excipients; Fanconi Syndrome; Nephrotic Syndrome; Polyethylene Glycols; Solubility; Suppositories | 2012 |
Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.
Topics: Adolescent; Biomarkers; Chemistry, Pharmaceutical; Creatinine; Cysteamine; Cystinosis; Delayed-Action Preparations; Drug Administration Schedule; Fanconi Syndrome; Female; Glomerular Filtration Rate; Humans; Kidney; Leukocyte Count; Male; Nephrotic Syndrome; Time Factors; Treatment Outcome; Young Adult | 2013 |